Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis
文献类型:期刊论文
作者 | Shao, Meijuan3,4; Yan, Yuxi2,3; Zhu, Fenghua3; Yang, Xiaoqian3; Qi, Qing3; Yang, Fangming3,4; Hao, Tingting3,4; Lin, Zemin3; He, Peilan3; Zhou, Yu3 |
刊名 | FRONTIERS IN PHARMACOLOGY |
出版日期 | 2022-09-01 |
卷号 | 13页码:18 |
关键词 | SM934 colitis intestinal epithelial barrier apoptosis pyroptosis NLRP3/caspase-1/GSDMD MAPK/NF-kB |
DOI | 10.3389/fphar.2022.849014 |
通讯作者 | He, Shijun(heshijun@simm.ac.cn) ; Zuo, Jianping(jpzuo@simm.ac.cn) |
英文摘要 | Intestinal barrier disruption due to the intestinal epithelial cells' (IECs) death is one of the critical pathological features of inflammatory bowel diseases (IBDs). SM934, an artemisinin analog, has previously been proven to ameliorate colitis induced by dextran sulfate sodium (DSS) in mice by suppressing inflammation response. In this study, we investigated the protective effects of SM934 on the epithelial barrier and the underlying mechanism in trinitrobenzene sulfonic acid (TNBS)-induced colitis mice. We demonstrated that SM934 restored the body weight and colon length, and improved the intestine pathology. Furthermore, SM934 treatment preserved the intestinal barrier function via decreasing the intestinal permeability, maintaining epithelial tight junction (TJ) protein expressions, and preventing apoptosis of epithelial cells, which were observed both in the colon tissue and the tumor necrosis factor-alpha (TNF-alpha)-induced human colonic epithelial cell line HT-29. Specifically, SM934 reduced the pyroptosis of IECs exposed to pathogenic signaling and inhibited pyroptosis-related factors such as NOD-like receptor family pyrin domain containing 3 (NLRP3), adapter apoptosis-associated speck-like protein (ASC), cysteine protease-1 (caspase-1), gasdermin (GSDMD), interleukin-18 (IL-18), and high-mobility group box 1 (HMGB1) both in colon tissue and lipopolysaccharide (LPS) and adenosine triphosphate (ATP) co-stimulated HT-29 cells in vitro. Moreover, SM934 interdicted pyroptosis via blocking the transduction of mitogen-activated protein kinase (MAPK) and nuclear factor-kB (NF-kB) signaling pathways. In conclusion, SM934 protected TNBS-induced colitis against intestinal barrier disruption by inhibiting the apoptosis and pyroptosis of epithelial cells via the NLRP3/NF-kappa B/MAPK signal axis, and intestinal barrier protection in company with an anti-inflammatory strategy might yield greater benefits in IBD treatment. |
WOS关键词 | NLRP3 INFLAMMASOME ACTIVATION ; BOWEL DISEASES ; CROHNS-DISEASE ; E-CADHERIN ; MICE ; PERMEABILITY ; PATHOGENESIS ; PROTECTS ; CELLS |
资助项目 | Shanghai Municipal Science and Technology Major Project ; Science and Technology Commission of Shanghai Municipality[21S11911000] ; National Natural Science Foundation of China[81871240] ; National Natural Science Foundation of China[81673445] ; Personalized Medicines-Molecular Signature-based Drug Discovery and Development ; National Science and Technology Major Project New Drug Creation and Manufacturing Program, China[2017ZX09101002-002-010] |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | FRONTIERS MEDIA SA |
WOS记录号 | WOS:000859298200001 |
源URL | [http://119.78.100.183/handle/2S10ELR8/302643] |
专题 | 新药研究国家重点实验室 |
通讯作者 | He, Shijun; Zuo, Jianping |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Lab Antiinflammat, Shanghai, Peoples R China 2.Univ Chinese Acad Sci, Beijing, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, State Key Lab Drug Res, Shanghai, Peoples R China 4.Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Shao, Meijuan,Yan, Yuxi,Zhu, Fenghua,et al. Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis[J]. FRONTIERS IN PHARMACOLOGY,2022,13:18. |
APA | Shao, Meijuan.,Yan, Yuxi.,Zhu, Fenghua.,Yang, Xiaoqian.,Qi, Qing.,...&Zuo, Jianping.(2022).Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis.FRONTIERS IN PHARMACOLOGY,13,18. |
MLA | Shao, Meijuan,et al."Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis".FRONTIERS IN PHARMACOLOGY 13(2022):18. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。